ANP Technologies, Inc. (ANP) announced that its drug master file (DMF) on its novel, nano-encapsulating polymer-based drug excipient, ANP001B has been accepted and published by the U.S. Food & Drug ...
Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here. NEWARK, Del.--(BUSINESS WIRE)-- ANP Technologies, Inc. (ANP) announced that its drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results